Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Memantine May Benefit Cognitively Impaired AIDS Patients
Link ID 442
Title Memantine May Benefit Cognitively Impaired AIDS Patients
Url http://www.medscape.com/viewarticle/565156?src=rss
Description Memantine, an uncompetitive antagonist of the N-methyl-D-aspartate receptor, might ameliorate HIV-associated cognitive impairment, researchers report. Although their 16-week study showed no clear clinical benefit, possible neuroprotective action was demonstrated by proton magnetic resonance spectroscopy (MRS). Reuters Health Information
Category Articles > HIV/AIDS
Keywords
Date Nov 6, 2007
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > HIV/AIDS
1. Literature Commentary by Dr. John G. Bartlett -- HIV Comorbidities and Adverse Effects, December 200
  In this review and commentary: relative risk for myocardial infarction with HIV infection and antiretroviral drugs (ARVs) by class; ARVs and risk factors for chronic renal failure.
Medscape HIV/AIDS
Category:   Articles > HIV/AIDS


2. Virus Subtype Affects Progression of HIV-1 Infection in Uganda
  The progression of human immunodeficiency virus type 1 (HIV-1) disease is affected by the virus subtype, according to a recent study based on research ongoing in Rakai, Uganda, since 1994 and published in the March 1 issue of the Journal of Infectious Diseases. Reuters Health Information
Category:   Articles > HIV/AIDS


3. Acyclovir Used to Suppress HSV-2 Does Not Affect HIV Acquisition
  Acyclovir treatment does not reduce the incidence of HIV-1 infection in sexually active individuals who are seropositive for herpes simplex virus 2 (HSV-2), according to results of a multinational clinical trial reported in the June 21st issue of The Lancet. Reuters Health Information
Category:   Articles > HIV/AIDS


4. Determinants of HIV Progression and Assessment of the Optimal Time to Initiate Highly Active Antiret
  When is the best time to start HAART; before the CD4 count falls to lower than 350 cells/microL?
JAIDS: Journal of Acquired Immune Deficiency Syndromes
Category:   Articles > HIV/AIDS


5. Current and Future Treatments of HIV-Associated Dyslipidemia
  The dyslipidemia associated with HIV is common and is attributed to HIV itself and/or the antiretroviral therapy used to treat HIV. What will the updated guidelines suggest to help these patients?
Future Lipidology
Category:   Articles > HIV/AIDS




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS